Salmonella spp.: For 2021, 24 MSs, plus Iceland and Norway provided data on antimicrobial resistance (AMR) in human Salmonella isolates. Twenty‐one countries reported measured values and four reported results interpreted as susceptible standard dosing regimen, susceptible increased exposure or resistant (SIR) according to the clinical breakpoints (CBPs) applied. One country reported results categorised as predicted wild type or predicted non‐wild type based on analysis of bacterial genomes (Table F.1).

Campylobacter spp.: For 2021, 22 MSs, plus Iceland and Norway provided AMR data from human isolates. Fifteen countries reported measured values, seven reported results interpreted as susceptible standard dosing regimen, susceptible increased exposure or resistant (SIR) according to the clinical breakpoints (CBPs) applied and two countries (Ireland and Sweden) reported result categorised as predicted wild type or predicted non‐wild type based on analysis of bacterial genomes (Table F.2).